{"entity":{"type":"insider","cik":"0001577021","url":"/insider/0001577021","json_url":"/insider/0001577021.json","name":"Copeland Robert A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":28,"first":"2013-12-03","last":"2017-06-07","span_basis":"filed_date"},"name_variants":[{"name":"Copeland Robert A","source":"filing","n_filings":28,"first_seen":"2013-12-03","last_seen":"2017-06-07"}],"transactions":[{"id":4541220,"accession":"0001209191-17-038262","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-038262","line_url":"/filing/0001209191-17-038262#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Commons Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":13.45,"price_display":"13.45","price_state":"stated","total_value":33625.0,"total_display":"33,625.00","total_whole":"33,625","shares_owned_after":31538.0,"shares_owned_after_display":"31,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-06","filed_date":"2017-06-07","scope":"insider"},{"id":4445188,"accession":"0001209191-17-029545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-029545","line_url":"/filing/0001209191-17-029545#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Commons Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.4425,"price_display":"17.44","price_state":"stated","total_value":87212.5,"total_display":"87,212.50","total_whole":"87,213","shares_owned_after":31538.0,"shares_owned_after_display":"31,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-02","filed_date":"2017-05-03","scope":"insider"},{"id":4739070,"accession":"0001209191-17-025793","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-025793","line_url":"/filing/0001209191-17-025793","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Commons Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.361,"price_display":"16.36","price_state":"stated","total_value":81805.0,"total_display":"81,805.00","total_whole":"81,805","shares_owned_after":34038.0,"shares_owned_after_display":"34,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider","n_lines":2},{"id":2109107,"accession":"0001209191-16-135122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-135122","line_url":"/filing/0001209191-16-135122#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"CommonStock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":10.3729,"price_display":"10.37","price_state":"stated","total_value":41491.6,"total_display":"41,491.60","total_whole":"41,492","shares_owned_after":31538.0,"shares_owned_after_display":"31,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":3293585,"accession":"0001209191-16-131945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-131945","line_url":"/filing/0001209191-16-131945#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":10.0319,"price_display":"10.03","price_state":"stated","total_value":40127.6,"total_display":"40,127.60","total_whole":"40,128","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-07","scope":"insider"},{"id":2694924,"accession":"0001209191-16-088021","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-088021","line_url":"/filing/0001209191-16-088021","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4185.0,"shares_display":"4,185","price_per_share":15.5754,"price_display":"15.58","price_state":"stated","total_value":65183.049,"total_display":"65,183.05","total_whole":"65,183","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-04","scope":"insider","n_lines":2},{"id":8582389,"accession":"0001209191-15-084097","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-084097","line_url":"/filing/0001209191-15-084097","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Common stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4185.0,"shares_display":"4,185","price_per_share":13.8215,"price_display":"13.82","price_state":"stated","total_value":57842.9775,"total_display":"57,842.98","total_whole":"57,843","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-07","filed_date":"2015-12-08","scope":"insider","n_lines":2},{"id":8084455,"accession":"0001209191-15-079292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-079292","line_url":"/filing/0001209191-15-079292#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4185.0,"shares_display":"4,185","price_per_share":16.2626,"price_display":"16.26","price_state":"stated","total_value":68058.981,"total_display":"68,058.98","total_whole":"68,059","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-09","filed_date":"2015-11-10","scope":"insider"},{"id":8696751,"accession":"0001209191-15-074017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-074017","line_url":"/filing/0001209191-15-074017#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Common Stock, part value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4185.0,"shares_display":"4,185","price_per_share":14.4277,"price_display":"14.43","price_state":"stated","total_value":60379.9245,"total_display":"60,379.92","total_whole":"60,380","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-05","filed_date":"2015-10-05","scope":"insider"},{"id":8793892,"accession":"0001209191-15-070239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-070239","line_url":"/filing/0001209191-15-070239#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4185.0,"shares_display":"4,185","price_per_share":19.575,"price_display":"19.58","price_state":"stated","total_value":81921.375,"total_display":"81,921.38","total_whole":"81,921","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-10","scope":"insider"},{"id":8793743,"accession":"0001209191-15-064245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-064245","line_url":"/filing/0001209191-15-064245#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8370.0,"shares_display":"8,370","price_per_share":22.1896,"price_display":"22.19","price_state":"stated","total_value":185726.952,"total_display":"185,726.95","total_whole":"185,727","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-05","scope":"insider"},{"id":8495532,"accession":"0001209191-15-060166","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-060166","line_url":"/filing/0001209191-15-060166","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (President of Research and CSO)","role_mark":"O","role_mark_label":"Officer (President of Research and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of Research and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8371.0,"shares_display":"8,371","price_per_share":22.86445479632063,"price_display":"22.86","price_state":"stated","total_value":191398.3511,"total_display":"191,398.35","total_whole":"191,398","shares_owned_after":4185.0,"shares_owned_after_display":"4,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-06","filed_date":"2015-07-08","scope":"insider","n_lines":2},{"id":6388615,"accession":"0001209191-14-070101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-070101","line_url":"/filing/0001209191-14-070101#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.6818,"price_display":"22.68","price_state":"stated","total_value":453636.0,"total_display":"453,636.00","total_whole":"453,636","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-19","scope":"insider"},{"id":7055401,"accession":"0001209191-14-066379","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-066379","line_url":"/filing/0001209191-14-066379","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":25.474999,"price_display":"25.47","price_state":"stated","total_value":509499.98,"total_display":"509,499.98","total_whole":"509,500","shares_owned_after":3700.0,"shares_owned_after_display":"3,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-03","filed_date":"2014-11-04","scope":"insider","n_lines":2},{"id":6531494,"accession":"0001209191-14-062699","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-062699","line_url":"/filing/0001209191-14-062699","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":26.90153,"price_display":"26.90","price_state":"stated","total_value":538030.6,"total_display":"538,030.60","total_whole":"538,031","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-09","scope":"insider","n_lines":2},{"id":6768528,"accession":"0001209191-14-059655","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-059655","line_url":"/filing/0001209191-14-059655#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":25.5495,"price_display":"25.55","price_state":"stated","total_value":510990.0,"total_display":"510,990.00","total_whole":"510,990","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-22","filed_date":"2014-09-24","scope":"insider"},{"id":6913372,"accession":"0001209191-14-053490","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-053490","line_url":"/filing/0001209191-14-053490","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10830.0,"shares_display":"10,830","price_per_share":36.067651708217916,"price_display":"36.07","price_state":"stated","total_value":390612.668,"total_display":"390,612.67","total_whole":"390,613","shares_owned_after":1326.0,"shares_owned_after_display":"1,326","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-18","filed_date":"2014-08-19","scope":"insider","n_lines":4},{"id":7034820,"accession":"0001209191-14-050709","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-050709","line_url":"/filing/0001209191-14-050709","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":29.41734741,"price_display":"29.42","price_state":"stated","total_value":588346.9482,"total_display":"588,346.95","total_whole":"588,347","shares_owned_after":13732.0,"shares_owned_after_display":"13,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-04","filed_date":"2014-08-05","scope":"insider","n_lines":2},{"id":6948765,"accession":"0001209191-14-043629","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-043629","line_url":"/filing/0001209191-14-043629","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":28.42060768,"price_display":"28.42","price_state":"stated","total_value":568412.1536,"total_display":"568,412.15","total_whole":"568,412","shares_owned_after":10489.0,"shares_owned_after_display":"10,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-23","filed_date":"2014-06-25","scope":"insider","n_lines":2},{"id":6229966,"accession":"0001209191-14-042426","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-042426","line_url":"/filing/0001209191-14-042426","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25012.0,"shares_display":"25,012","price_per_share":26.3829,"price_display":"26.38","price_state":"stated","total_value":659889.0948,"total_display":"659,889.09","total_whole":"659,889","shares_owned_after":5525.0,"shares_owned_after_display":"5,525","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-06-16","filed_date":"2014-06-18","scope":"insider","n_lines":2},{"id":6875570,"accession":"0001209191-14-039103","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-039103","line_url":"/filing/0001209191-14-039103","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38400.0,"shares_display":"38,400","price_per_share":22.293370833333334,"price_display":"22.29","price_state":"stated","total_value":856065.44,"total_display":"856,065.44","total_whole":"856,065","shares_owned_after":20661.0,"shares_owned_after_display":"20,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-02","filed_date":"2014-06-04","scope":"insider","n_lines":2},{"id":6414042,"accession":"0001209191-14-035949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-035949","line_url":"/filing/0001209191-14-035949","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":22.2761,"price_display":"22.28","price_state":"stated","total_value":111380.5,"total_display":"111,380.50","total_whole":"111,381","shares_owned_after":18281.0,"shares_owned_after_display":"18,281","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-19","filed_date":"2014-05-21","scope":"insider","n_lines":2},{"id":6614436,"accession":"0001209191-14-031302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-031302","line_url":"/filing/0001209191-14-031302","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.2884,"price_display":"21.29","price_state":"stated","total_value":212884.0,"total_display":"212,884.00","total_whole":"212,884","shares_owned_after":20831.0,"shares_owned_after_display":"20,831","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-05-05","filed_date":"2014-05-05","scope":"insider","n_lines":2},{"id":6294514,"accession":"0001209191-14-029963","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-029963","line_url":"/filing/0001209191-14-029963#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13800.0,"shares_display":"13,800","price_per_share":20.7308,"price_display":"20.73","price_state":"stated","total_value":286085.04,"total_display":"286,085.04","total_whole":"286,085","shares_owned_after":24911.0,"shares_owned_after_display":"24,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-28","filed_date":"2014-04-30","scope":"insider"},{"id":6754913,"accession":"0001209191-14-009943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-009943","line_url":"/filing/0001209191-14-009943#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19179.0,"shares_display":"19,179","price_per_share":29.25,"price_display":"29.25","price_state":"stated","total_value":560985.75,"total_display":"560,985.75","total_whole":"560,986","shares_owned_after":24911.0,"shares_owned_after_display":"24,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-12","scope":"insider"},{"id":6787784,"accession":"0001209191-14-003437","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-003437","line_url":"/filing/0001209191-14-003437","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15006.0,"shares_display":"15,006","price_per_share":39.267883166733306,"price_display":"39.27","price_state":"stated","total_value":589253.8548,"total_display":"589,253.85","total_whole":"589,254","shares_owned_after":47948.0,"shares_owned_after_display":"47,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-13","filed_date":"2014-01-15","scope":"insider","n_lines":4},{"id":4610305,"accession":"0001209191-13-057504","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-057504","line_url":"/filing/0001209191-13-057504#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":21.2054,"price_display":"21.21","price_state":"stated","total_value":97544.84,"total_display":"97,544.84","total_whole":"97,545","shares_owned_after":53544.0,"shares_owned_after_display":"53,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-16","filed_date":"2013-12-17","scope":"insider"},{"id":5309069,"accession":"0001209191-13-055052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-055052","line_url":"/filing/0001209191-13-055052","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001577021","owner_name":"Copeland Robert A","owner_display_name":"Copeland Robert A","owner_url":"/insider/0001577021","role":"Officer (EVP and CSO)","role_mark":"O","role_mark_label":"Officer (EVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CSO","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.6964,"price_display":"20.70","price_state":"stated","total_value":103482.0,"total_display":"103,482.00","total_whole":"103,482","shares_owned_after":53544.0,"shares_owned_after_display":"53,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-03","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":47,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":47},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Officer (President of Research and CSO)","n_filings":28,"first_seen":"2013-12-03","last_seen":"2017-06-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001577021","retrieved_at":"2026-08-27T11:01:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}